A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells
- 1 January 2016
- journal article
- research article
- Vol. 36 (1) , 49-60
Abstract
Background: The survival rate of patients with head and neck squamous cell carcinoma (HNSCC) stands at approximately 50% and this has not improved in decades. This study developed a novel sirtuin-3 (SIRT3) inhibitor (LC-0296) and examined its role in altering HNSCC tumorigenesis. Materials and Methods: The effect of the SIRT3 inhibitor, LC-0296, on cell survival, proliferation, and apoptosis, and reactive oxygen species levels in HNSCC cells were studied. Results: LC-0296 reduces cell proliferation and promotes apoptosis of HNSCC cells but not of normal human oral keratinocytes. This inhibitory effect is mediated, in part, via modulation of reactive oxygen species levels. Additionally, LC-0296 works synergistically to increase the sensitivity of HNSCC cells to radiation and cisplatin treatment. Conclusion: Development of novel SIRT3 inhibitors, such as LC-0296, might enable the development of new targeted therapies to treat and improve the survival rate of patients with head and neck cancer.Keywords
This publication has 51 references indexed in Scilit:
- Sirtuin Inhibitors as Anticancer AgentsFuture Medicinal Chemistry, 2014
- Development of Pyrazolone and Isoxazol-5-one Cambinol Analogues as Sirtuin InhibitorsJournal of Medicinal Chemistry, 2014
- Identification of novel SIRT3 inhibitor scaffolds by virtual screeningBioorganic & Medicinal Chemistry Letters, 2013
- Sorting out functions of sirtuins in cancerOncogene, 2013
- Therapeutic potential of activators and inhibitors of sirtuinsBioFactors, 2010
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?International Journal of Biological Sciences, 2009
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- Mitochondrial reactive oxygen species in cell death signalingBiochimie, 2002
- Production of large amounts of hydrogen peroxide by human tumor cells.1991
- Radiosensitivity of Head and Neck Cancer Cells In Vitro: A 96-Well Plate Clonogenic Cell Assay for Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1988